Compile Data Set for Download or QSAR
Report error Found 16 Enz. Inhib. hit(s) with all data for entry = 9056
TargetALK tyrosine kinase receptor(Human)
Suzhou Zelgen Biopharmaceuticals

US Patent
LigandPNGBDBM50436850(CHEMBL2403108 | CERITINIB | US10053458, Comparativ...)
Affinity DataIC50: 5nMAssay Description:96-well plates was coated under 37° C. with coating buffer (125 μl/well) overnight, and coating buffer was polypeptide substrate [Poly (4:1 Glu,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetALK tyrosine kinase receptor(Human)
Suzhou Zelgen Biopharmaceuticals

US Patent
LigandPNGBDBM50436850(CHEMBL2403108 | CERITINIB | US10053458, Comparativ...)
Affinity DataIC50: 5nMAssay Description:96-well plates was coated under 37° C. with coating buffer (125 μl/well) overnight, and coating buffer was polypeptide substrate [Poly (4:1 Glu,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetALK tyrosine kinase receptor(Human)
Suzhou Zelgen Biopharmaceuticals

US Patent
LigandPNGBDBM50436850(CHEMBL2403108 | CERITINIB | US10053458, Comparativ...)
Affinity DataIC50: 5nMAssay Description:96-well plates was coated under 37° C. with coating buffer (125 μl/well) overnight, and coating buffer was polypeptide substrate [Poly (4:1 Glu,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetALK tyrosine kinase receptor(Human)
Suzhou Zelgen Biopharmaceuticals

US Patent
LigandPNGBDBM50436850(CHEMBL2403108 | CERITINIB | US10053458, Comparativ...)
Affinity DataIC50: 5nMAssay Description:96-well plates was coated under 37° C. with coating buffer (125 μl/well) overnight, and coating buffer was polypeptide substrate [Poly (4:1 Glu,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetALK tyrosine kinase receptor(Human)
Suzhou Zelgen Biopharmaceuticals

US Patent
LigandPNGBDBM50436850(CHEMBL2403108 | CERITINIB | US10053458, Comparativ...)
Affinity DataIC50: 5nMAssay Description:96-well plates was coated under 37° C. with coating buffer (125 μl/well) overnight, and coating buffer was polypeptide substrate [Poly (4:1 Glu,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetALK tyrosine kinase receptor(Human)
Suzhou Zelgen Biopharmaceuticals

US Patent
LigandPNGBDBM50436850(CHEMBL2403108 | CERITINIB | US10053458, Comparativ...)
Affinity DataIC50: 5nMAssay Description:96-well plates was coated under 37° C. with coating buffer (125 μl/well) overnight, and coating buffer was polypeptide substrate [Poly (4:1 Glu,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetALK tyrosine kinase receptor(Human)
Suzhou Zelgen Biopharmaceuticals

US Patent
LigandPNGBDBM50436850(CHEMBL2403108 | CERITINIB | US10053458, Comparativ...)
Affinity DataIC50: 5nMAssay Description:96-well plates was coated under 37° C. with coating buffer (125 μl/well) overnight, and coating buffer was polypeptide substrate [Poly (4:1 Glu,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetALK tyrosine kinase receptor(Human)
Suzhou Zelgen Biopharmaceuticals

US Patent
LigandPNGBDBM50436850(CHEMBL2403108 | CERITINIB | US10053458, Comparativ...)
Affinity DataIC50: 5nMAssay Description:96-well plates was coated under 37° C. with coating buffer (125 μl/well) overnight, and coating buffer was polypeptide substrate [Poly (4:1 Glu,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetALK tyrosine kinase receptor(Human)
Suzhou Zelgen Biopharmaceuticals

US Patent
LigandPNGBDBM50436850(CHEMBL2403108 | CERITINIB | US10053458, Comparativ...)
Affinity DataIC50: 5nMAssay Description:96-well plates was coated under 37° C. with coating buffer (125 μl/well) overnight, and coating buffer was polypeptide substrate [Poly (4:1 Glu,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetALK tyrosine kinase receptor(Human)
Suzhou Zelgen Biopharmaceuticals

US Patent
LigandPNGBDBM50436850(CHEMBL2403108 | CERITINIB | US10053458, Comparativ...)
Affinity DataIC50: 5nMAssay Description:96-well plates was coated under 37° C. with coating buffer (125 μl/well) overnight, and coating buffer was polypeptide substrate [Poly (4:1 Glu,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetALK tyrosine kinase receptor(Human)
Suzhou Zelgen Biopharmaceuticals

US Patent
LigandPNGBDBM50436850(CHEMBL2403108 | CERITINIB | US10053458, Comparativ...)
Affinity DataIC50: 5nMAssay Description:96-well plates was coated under 37° C. with coating buffer (125 μl/well) overnight, and coating buffer was polypeptide substrate [Poly (4:1 Glu,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetALK tyrosine kinase receptor(Human)
Suzhou Zelgen Biopharmaceuticals

US Patent
LigandPNGBDBM50436850(CHEMBL2403108 | CERITINIB | US10053458, Comparativ...)
Affinity DataIC50: 5nMAssay Description:96-well plates was coated under 37° C. with coating buffer (125 μl/well) overnight, and coating buffer was polypeptide substrate [Poly (4:1 Glu,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetALK tyrosine kinase receptor(Human)
Suzhou Zelgen Biopharmaceuticals

US Patent
LigandPNGBDBM50436850(CHEMBL2403108 | CERITINIB | US10053458, Comparativ...)
Affinity DataIC50: 5nMAssay Description:96-well plates was coated under 37° C. with coating buffer (125 μl/well) overnight, and coating buffer was polypeptide substrate [Poly (4:1 Glu,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetALK tyrosine kinase receptor(Human)
Suzhou Zelgen Biopharmaceuticals

US Patent
LigandPNGBDBM50436850(CHEMBL2403108 | CERITINIB | US10053458, Comparativ...)
Affinity DataIC50: 5nMAssay Description:96-well plates was coated under 37° C. with coating buffer (125 μl/well) overnight, and coating buffer was polypeptide substrate [Poly (4:1 Glu,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetALK tyrosine kinase receptor(Human)
Suzhou Zelgen Biopharmaceuticals

US Patent
LigandPNGBDBM50436850(CHEMBL2403108 | CERITINIB | US10053458, Comparativ...)
Affinity DataIC50: 5nMAssay Description:96-well plates was coated under 37° C. with coating buffer (125 μl/well) overnight, and coating buffer was polypeptide substrate [Poly (4:1 Glu,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetALK tyrosine kinase receptor(Human)
Suzhou Zelgen Biopharmaceuticals

US Patent
LigandPNGBDBM50436850(CHEMBL2403108 | CERITINIB | US10053458, Comparativ...)
Affinity DataIC50: 5nMAssay Description:96-well plates was coated under 37° C. with coating buffer (125 μl/well) overnight, and coating buffer was polypeptide substrate [Poly (4:1 Glu,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2020
Entry Details
US Patent
PDB3D3D Structure (crystal)